Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 88

1.

MRT trotz ungeeigneten Schrittmachers.

Radke PW.

MMW Fortschr Med. 2017 Apr;159(7):36. doi: 10.1007/s15006-017-9530-8. German. No abstract available.

PMID:
28417387
2.

A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trial.

de Waha A, Sandner S, von Scheidt M, Boening A, Koch-Buettner K, Hammel D, Hambrecht R, Danner BC, Schöndube FA, Goerlach G, Fischlein T, Schmoeckel M, Oberhoffer M, Schulz R, Walther T, Ziegelhöffer T, Knosalla C, Schönrath F, Beyersdorf F, Siepe M, Attmann T, Misfeld M, Mohr FW, Sievers HH, Joost A, Putman LM, Laufer G, Hamm C, Zeymer U, Kastrati A, Radke PW, Lange R, Cremer J, Schunkert H.

Am Heart J. 2016 Sep;179:69-76. doi: 10.1016/j.ahj.2016.05.017. Epub 2016 Jun 18.

PMID:
27595681
3.

[CT angiography in suspected coronary heart disease has no advantage].

Radke PW.

MMW Fortschr Med. 2015 Oct 8;157(17):42. German. No abstract available.

PMID:
26759877
4.

The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX.

Gutierrez JA, Harrington RA, Blankenship JC, Stone GW, Steg PG, Gibson CM, Hamm CW, Price MJ, Généreux P, Prats J, Deliargyris EN, Mahaffey KW, White HD, Bhatt DL; CHAMPION PHOENIX Investigators..

Eur Heart J. 2016 Apr 7;37(14):1122-30. doi: 10.1093/eurheartj/ehv498. Epub 2015 Sep 23.

5.

[Automatic defibrillators are lifesavers].

Radke PW.

MMW Fortschr Med. 2015 Apr 30;157(8):36. doi: 10.1007/s15006-015-3027-0. German. No abstract available.

PMID:
26012678
6.

[Immediate ticagrelor administration useful in STEMI].

Radke PW.

MMW Fortschr Med. 2014 Nov 13;156 Spec no 2:30. German. No abstract available.

PMID:
25552009
7.

Cobalt-chromium KAname™ coRonary stEnt system in the treatment of patients with coronary artery disease (KARE study).

Carrie D, Schächinger V, Danzi GB, Macaya C, Zeymer U, Putnikovic B, Iniguez A, Moreno R, Mehmedbegovic Z, Beleslin B; KARE INVESTIGATORS..

J Interv Cardiol. 2014 Oct;27(5):491-9. doi: 10.1111/joic.12144. Epub 2014 Aug 30.

PMID:
25175153
8.

Networks for improving care in patients with acute coronary syndrome: A framework.

Radke PW, Halvorsen S, Jukema JW, Kolh P, Annemans L, Postma MJ, Ardissino D, Kristensen SD, Bassand JP, Collet JP, Morais J, Tuñón J, Halcox J.

Acute Card Care. 2014 Jun;16(2):41-8. doi: 10.3109/17482941.2014.881502. Epub 2014 Mar 21.

PMID:
24654609
9.

Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type.

Camenzind E, Boersma E, Wijns W, Mauri L, Rademaker-Havinga T, Ordoubadi FF, Suttorp MJ, Al Kurdi M, Steg PG; PROTECT Steering Committee and Investigators..

Eur Heart J. 2014 Aug 1;35(29):1932-48. doi: 10.1093/eurheartj/ehu084. Epub 2014 Mar 13.

PMID:
24627416
10.

Relative efficacy of bivalirudin versus heparin monotherapy in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: a network meta-analysis.

Kinnaird T, Medic G, Casella G, Schiele F, Kaul U, Radke PW, Eijgelshoven I, Bergman G, Chew DP.

J Blood Med. 2013 Oct 2;4:129-40. doi: 10.2147/JBM.S50595. Review.

11.

Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial.

Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, de Waha A, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Lauer B, Böhm M, Ebelt H, Schneider S, Werdan K, Schuler G; Intraaortic Balloon Pump in cardiogenic shock II (IABP-SHOCK II) trial investigators..

Lancet. 2013 Nov 16;382(9905):1638-45. doi: 10.1016/S0140-6736(13)61783-3. Epub 2013 Sep 3.

PMID:
24011548
12.

Effect of platelet inhibition with cangrelor during PCI on ischemic events.

Bhatt DL, Stone GW, Mahaffey KW, Gibson CM, Steg PG, Hamm CW, Price MJ, Leonardi S, Gallup D, Bramucci E, Radke PW, Widimský P, Tousek F, Tauth J, Spriggs D, McLaurin BT, Angiolillo DJ, Généreux P, Liu T, Prats J, Todd M, Skerjanec S, White HD, Harrington RA; CHAMPION PHOENIX Investigators..

N Engl J Med. 2013 Apr 4;368(14):1303-13. doi: 10.1056/NEJMoa1300815. Epub 2013 Mar 10.

13.

B-type natriuretic peptide and risk of contrast-induced acute kidney injury in acute ST-segment-elevation myocardial infarction: a substudy from the HORIZONS-AMI trial.

Jarai R, Dangas G, Huber K, Xu K, Brodie BR, Witzenbichler B, Metzger DC, Radke PW, Yu J, Claessen BE, Genereux P, Mehran R, Stone GW.

Circ Cardiovasc Interv. 2012 Dec;5(6):813-20. doi: 10.1161/CIRCINTERVENTIONS.112.972356. Epub 2012 Nov 27.

14.

Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial.

Camenzind E, Wijns W, Mauri L, Kurowski V, Parikh K, Gao R, Bode C, Greenwood JP, Boersma E, Vranckx P, McFadden E, Serruys PW, O'Neil WW, Jorissen B, Van Leeuwen F, Steg PG; PROTECT Steering Committee and Investigators..

Lancet. 2012 Oct 20;380(9851):1396-405. doi: 10.1016/S0140-6736(12)61336-1. Epub 2012 Aug 27.

PMID:
22951082
15.

Intraaortic balloon support for myocardial infarction with cardiogenic shock.

Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Fuhrmann J, Böhm M, Ebelt H, Schneider S, Schuler G, Werdan K; IABP-SHOCK II Trial Investigators..

N Engl J Med. 2012 Oct 4;367(14):1287-96. doi: 10.1056/NEJMoa1208410. Epub 2012 Aug 26.

16.

[The thickened left ventricle: etiology, differential diagnosis and implications for cardiovascular radiology].

Bischoff P, Radke PW, Barkhausen J, Hunold P.

Rofo. 2012 Aug;184(8):697-705. doi: 10.1055/s-0032-1312891. Epub 2012 Jun 18. Review. German.

PMID:
22711247
17.

Elevation of matrix metalloproteinases in different areas of ascending aortic aneurysms in patients with bicuspid and tricuspid aortic valves.

Mohamed SA, Noack F, Schoellermann K, Karluss A, Radtke A, Schult-Badusche D, Radke PW, Wenzel BE, Sievers HH.

ScientificWorldJournal. 2012;2012:806261. doi: 10.1100/2012/806261. Epub 2012 May 3.

18.

Release patterns of copeptin and troponin in Tako-Tsubo cardiomyopathy.

Burgdorf C, Schubert A, Schunkert H, Kurowski V, Radke PW.

Peptides. 2012 Apr;34(2):389-94. doi: 10.1016/j.peptides.2012.01.022. Epub 2012 Feb 4.

PMID:
22326519
19.

Preclinical evaluation of a novel drug-eluting balloon in an animal model of in-stent stenosis.

Joner M, Radke PW, Byrne RA, Hartwig S, Steigerwald K, Leclerc G, Wittchow E.

J Biomater Appl. 2013 Feb;27(6):717-26. doi: 10.1177/0885328211423784. Epub 2012 Jan 19.

PMID:
22262578
20.

Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients.

Radke PW, Joner M, Joost A, Byrne RA, Hartwig S, Bayer G, Steigerwald K, Wittchow E.

EuroIntervention. 2011 Oct 30;7(6):730-7. doi: 10.4244/EIJV7I6A116.

Supplemental Content

Loading ...
Support Center